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Abstract: Background: Little is known about the prevalence and risk factors of diabetes among
Gaza Palestinians, 64% of whom are refugees with exceeded sugar intake. We aimed to estimate the
prevalence of type 2 diabetes (T2D) and its association with added sugar intake among residents,
with regular visits to primary healthcare centers (PHCs) across Gaza. Methods: From October to
December of 2019, a cross-sectional survey was conducted among 1000 citizens and refugees in
nine PHCs selected from the five governorates of the Gaza Strip. Information on dietary intake,
medical history, and other risk factors was collected by trained health workers, using structured
questionnaires. Anthropometry and biochemical data were extracted from the PHC medical record
system. Results: Overall, the prevalence of diagnosed T2D and undiagnosed T2D were 45.2% and
16.8%, respectively, in adults aged 42 to 74 years, with the differences among citizens and refugees
(diagnosed: 46.2% vs. 43.8%; undiagnosed: 15.7% vs. 18.2%). The uncontrolled glycaemic rate was
41.9% and 36.8% for diagnosed patients in citizens and refugees, respectively. Among those without
a clinical diagnosis of T2D, after multivariable adjustment, daily added sugar intake was positively
associated with fasting glucose and the risk of undiagnosed T2D (odds ratio, 95% CI, highest vs.
lowest intake, was 2.71 (1.12–6.54) (p for trend < 0.001). In stratified analysis, the associations between
added sugar intake and the risk of undiagnosed T2D tend to be stronger among refugees or those
with higher body mass index. Conclusions: Among Palestinian adults, both citizens and refugees are
affected by T2D. Added sugar intake is associated with the risk of undiagnosed T2D.
Keywords: Gaza Strip; Palestinian; added sugar intake; type 2 diabetes
1. Introduction
Type 2 diabetes (T2D) and its complications have contributed to the global burden of mortality [1],
posing a major global health threat in both developed and developing countries [2,3]. In the Middle
East, approximately 46 million individuals were suffering from T2D from 2000 to 2018 [4]. There is a
lack of information about the prevalence of T2D in Palestine [5], possibly due to the large population
of scattered refugees across neighbouring countries, the presence of conflicts, wars, ongoing crises,
and the fragile nature of the healthcare system [6].
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According to the 2018 annual health report of the United Nations Relief and Works Agency
(UNRWA), 15.7% of refugees aged over 40 years were diagnosed with T2D in the Gaza Strip, Palestine [7].
Moreover, T2D and its complications account for approximately 5.7% of all Palestine deaths [8]. In the
past 20 years, people in the Gaza Strip have been facing poor surroundings and critical situations due to
sieges and border-closure conditions [9,10]. Refugees account for 64% of all Palestinian residents in the
Gaza Strip [11] and suffer from deteriorating living conditions, high poverty, low wages, and unhealthy
camp housing [12], with raised problems in malnutrition, food insecurity, and lack medical care [13,14].
However, direct population evidence linking such exposures with the prevalence of T2D was rarely
reported [15].
Suboptimal diet is one of the leading causes of poor health, including T2D [16,17]. In Gaza,
most Palestinian refugees receive monthly food supplies (sugar, rice, legumes, flour, and cooking oil)
and aids from humanitarian agencies, such as UNRWA and World Food Programme [18]. Moreover,
Palestinians consume large amounts of homemade desserts, cakes, sweetened tea, and coffee [19].
A community-based cross-sectional survey undertaken among Palestinians aged 30–65 years in the
West Bank showed that the mean annual intake of added sugar per household member was 37.8 kg
(≈105 g/day), contributing to 13–14% daily total energy intake [20]. It is approximately three times
what the American Heart Association recommends for the maximum amount of daily added sugar
intake (37.5 g for men and 25 g for women) [21].
Moreover, World Health Organization (WHO) suggests reducing free sugar consumption to
below 10% of total energy intake, at all stages of life, to minimize the risk of excessive weight
gain [22], and further reduction to 5% could have additional health benefits [23]. On the other hand,
diabetic patients with high added sugar intake can develop diabetic foot ulcers in the long-term,
especially for elderly adults [24]. It may have a negative impact on the quality of life and diabetes
self-management [25]. Thus, the diabetic patient should have special management of his/her nutrition,
including added sugar, which has a critical role in the wound-healing process [26].
To the best of our knowledge, the link between sugar intake and the prevalence of T2D among
Palestinians has not been explored. We aimed to evaluate the prevalence of T2D in Palestinian citizens
and refugees living in Gaza who attended the clinics and further explored the association of added
sugar intake with the risk of T2D.
2. Materials and Methods
2.1. Study Design and Participants
This is a cross-sectional study among residents who were regularly visiting the primary healthcare
centers (PHCs), the Ministry of Health (MOH), Gaza Strip, Palestine. The project was designed to
examine the prevalence of non-communicable diseases and conventional population-specific (e.g., living
conditions under long-lasting border conflicts) risk factors among Palestinian adults in the Gaza Strip
and served by the governmental PHCs.
The inclusion criteria included the following: (1) Palestinian residents (refugees or citizens),
(2) date of birth between 1 January 1944 and 31 December 2001, (3) living in the Gaza Strip for
14 years; and (4) registered at PHCs, Gaza. Exclusion criteria were as follows: (1) pregnant women
and (2) lacking data of existing biochemical variables from 2013 to 2019. Setting a precision of 0.05,
assuming a prevalence of T2D of 15.7% [7,27], we concluded that 956 participants would be sufficient
to provide 85% power to estimate the prevalence of T2D. Out of the total, 1000 participants were
finally included in the analysis, after excluding pregnant participants (n = 37) and participants whose
biochemical and anthropometric data were missing (n = 83). The participants of the research were
chosen from various clinics within the PHCs. We invited all the visitors during the working hours of
those clinics, from the early morning until afternoon.
All subjects gave their informed consent for inclusion before they participated in the study.
The study was approved by the Ethical Committee of Xi’an Jiaotong University Health Science Center,
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and it was conducted by following the Declaration of Helsinki. The protocol was approved by the Ethics
Committee of the Research Department at the Directorate General of Human Resources Development,
Ministry of Health, Gaza (PHRC/HC/576/19).
2.2. Sampling Approach
The Gaza Strip is divided into five governorates: North of Gaza, Gaza City, Midzone, Khan-Younis,
and Rafah [28]. A total of 51 PHCs are distributed across the Gaza Strip, which provides
residents (both citizens and refugees) specialized healthcare services, including tailored maternal and
family-planning programs, as well as permanent monitoring of non-communicable diseases (NCDs)
such as T2D [27]. We selected 9 out of 51 PHCs, the largest ones located in different governorates
across the Gaza Strip, as our study sites, to maximize our participants’ representativeness. One to
three PHCs were consequently selected from each governorate, matching the population’s size of each
governorate (Supplementary Materials Figure S1).
2.3. Data Collection
The initial version of the questionnaire was designed and then validated in two steps.
First, the research instrument was sent to medical experts, to express its simplicity, relativity, and
importance. Secondly, a pilot study was conducted among a small group of PHCs’ visitors (n = 30),
to verify the validity and reliability of the data-collection process before the formal data collection.
Minor changes were made to the data-collection approach for some items, by considering the results of
the pilot analysis. Furthermore, medical experts validated and reviewed the updated questionnaire,
to reconfirm the acceptability of the methods used to achieve the research goals. In the formal
data-collection process, the final version of the questionnaire was used, and the data from the pilot
study were not used in the final analysis.
The data were collected in two stages: (1) Face-to-face questionnaire interviews were conducted
for all participants, by trained health workers. (2) Anthropometric and biochemical parameters for
the same respondents were extracted by medical secretary staff, using their Electronic Health Record
System (E-Health), by matching their registration ID.
The questionnaire consisted of four parts: (1) sociodemographic data, including age, sex, marital
status, education level, working status, and household income; (2) medical history, including
diagnosis, duration, treatment status, and family history of non-communicable disease, including T2D;
(3) lifestyle information, including physical activity (International Physical Activity Questionnaire [29]),
dietary habits (adapted from questions used in the China Kadoorie Biobank [30]), tea and coffee
consumption, and smoking; (4) unique issues for the poor conditions of the Palestinian refugees and
citizens, such as living, housing conditions, injuries, loss of family members, and depression.
The Anthropometric variables, including weight, height, waist circumference, and blood pressure,
were extracted from the E-Health record system. Body mass index (BMI) was calculated based on
the BMI formula (BMI (kg/m2) = Weight (kg)/Height squared (m2)) [31]. In the daily routine work of
PHCs, the nursing staff measured height and weight for all clinic visitors, using stadiometers (Seca),
according to the WHO standardized protocols [31]. Waist circumference was routinely measured to
the nearest 1.0 cm, after breath out, using non-elastic tape around the middle waist, just above the
hipbones, according to the protocol of the National Institutes of Health [32]. Blood-pressure data were
extracted from the E-Health system. Their blood pressure was measured by the PHCs nursing staff,
in the right arm, after 5 min of rest, in a sitting position, by a single mercury sphygmomanometer.
Biochemical data were extracted from the E-health system: fasting blood glucose (FBG), Haemoglobin
A1c (HbA1c), total cholesterol, triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein
(LDL). All of these biochemical tests were assayed by medical laboratory technicians, using colorimetric
and kinetic assays, using an automated biochemical analyzer (ChemWell 2910, Awareness Technology,
CA, USA and Erba XL 200, Erba Diagnostics Mannheim, Germany).
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2.4. Outcome Definitions
T2D was defined as having a documented diagnosis by general practitioners in the PHCs, and those
cases were named diagnosed T2D in the present study. Among those without a clinical T2D diagnosis,
undiagnosed T2D was defined as having a fasting blood glucose (FBG) level ≥7.0 mmol/L (≥126 mg/dL).
Moreover, in a sensitivity analysis, for those without a clinical diagnosis of T2D, FBG was ≥7.0 mmol/L
(≥126 mg/dL) plus HbA1c ≥48 mmol/mol (≥6.5%). Uncontrolled diabetes was defined as having
HbA1c ≥53 mmol/mol (≥7.0%), according to the American Diabetes Association [33].
2.5. Statistical Analysis
All analyses were conducted by using STATA 14.0 (StataCorp, College Station, TX, USA).
Continuous variables were reported as mean values and standard deviations, while categorical
variables were presented as frequency and percentage. Chi-square and t-tests were used for comparison
of categorical data and continuous variables, respectively. To compare demographic characteristics
between groups, one-way variance analysis (ANOVA) was used if there were three or more groups.
The odds ratio (OR) and 95% confidence interval (CI) of T2D were calculated by using multivariable
logistic regression by average daily added sugar intake, after adjusting for sex, age, population
(refugees, citizens), region (North, Gaza City, Midzone, Khan Younis, and Rafah), household income
(<500 NIS, 500–1000 NIS, 1000–1500 NIS, >1500 NIS, and no constant income), education (low, moderate,
or high), smoking (yes or no), BMI (continuous), physical activity (low, moderate, or high), fruits and
vegetable intake (continuous), hypertension (having or not), and lipid profile (total cholesterol,
triglycerides, HDL, and LDL). Stratified analysis was conducted by sex, age (according to the median
≥ or < 59 years), BMI (according to the median ≥ or < 26.7 kg/m2), and population type (refugees or
citizens); the statistical significance level was set as a two-sided p < 0.05.
3. Results
3.1. Prevalence of T2D and Characteristics of the Participants
The mean age of the participants was 59.2 ± 7.5 years, and 46.8% were females. In total, 42.2% of
the participants were refugees, and 45.1% had a low education level. Furthermore, 85.4% of them
lacked constant income, and only 11.7% were employed (Table 1).
Overall, 45.2% of the participants were clinically diagnosed with T2D, and another 16.8% were
undiagnosed T2D. (Table 1) Moreover, clinically diagnosed T2D tended to be more prevalent in women,
age (40–50 years), citizens, unemployed, or from the north of Gaza, relative to their counterparties,
while undiagnosed T2D cases were more prevalent in women, age (40–50 years), refugees, Gaza City,
or employed. (Figure 1) Furthermore, 39.8% (95% CI 35.4–44.4) of the diagnosed T2D cases were
uncontrolled; 40.8% (95% CI 34.7–47.3) and 38.7% (95% CI 32.4–45.4) in men and women (Figure 2);
the highest uncontrolled glycaemic rate was 50.0% (95% CI 36.5–63.4) in Gaza City, while the lowest
was 32.3% (95% CI 23.7–42.3) in Khan Younis. Specifically, 11.3% (95% CI 9.5–13.4) had HbA1c value of
53 mmol/mol (7.0%) to 63 mmol/mol (7.9%), while the highest percentage was 17.3% (95% CI 15.1–19.7)
for those who had HbA1c value of 64 mmol/mol (8.0%) to 75 mmol/mol (9.0%), and 11.1% (95% CI
9.3–13.2) had HbA1c value higher than 75 mmol/mol (>9.0%). (Figure 2).
Compared with non-cases, participants diagnosed or undiagnosed with T2D had higher levels in
adiposity index, FBG, and HbA1c, and worse lipid profiles, where the mean (SD) BMI of the diagnosed
and undiagnosed T2D was 28.2 (3.7) kg/m2 and 28.5 (3.5) kg/m2, respectively, while it was 27.9 (3.7)
kg/m2 among the non-cases group (p = 0.189, Table 1), also the mean (SD) FBG of the diagnosed and
undiagnosed T2D was 12.5 (4.6) mmol/L, and 10.0 (3.1) mmol/L, respectively, while it was 5.6 (1.0)
mmol/L among the non-cases group (p < 0.001, Table 1).
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Table 1. Characteristics of study participants.a.








n = 380 p-Value
Age, years 59.2 (7.5) 59.1 (7.7) 58.5 (7.3) 59.4 (7.5) 0.455
Women 468 (46.8%) 217 (46.4%) 83 (17.7%) 168 (35.9 %) 0.034
Study regions
North 220 (22.0%) 101 (22.3%) 32 (19.1%) 87 (22.9%) 0.286
Gaza 122 (12.2%) 60 (13.3%) 26 (15.5%) 36 (9.5%)
Midzone 214 (21.4%) 103 (22.8%) 25 (14.8%) 86 (22.6%)
Khan Younis 223 (22.3%) 99 (21.9%) 41 (24.4%) 83 (21.8%)
Rafah 221 (22.1%) 89 (19.7%) 44 (26.2%) 88 (23.2%)
Refugees 422 (42.2%) 185 (40.9%) 76 (45.2%) 161 (42.4%) 0.625
Family size 6.9 (1.5) 6.9 (1.6) 6.7 (1.5) 6.9 (1.5) 0.099
Married 844 (84.4%) 373 (82.5%) 147 (87.5%) 324 (85.3%) 0.386
Education
Low 451 (45.1%) 208 (46.0%) 73 (43.4%) 170 (44.7%) 0.873
Moderate 295 (29.5%) 134 (29.7%) 47 (28.0%) 114 (30.0%)
High 254 (25.4%) 110 (24.3%) 48 (28.6%) 96 (25.3%)
Employed 117 (11.7%) 48 (10.6%) 20 (11.9%) 49 (12.8%) 0.594
Household income (NIS) 0.287
<500 51 (5.1%) 26 (5.7%) 11 (6.5%) 14 (3.7%)
500–1000 41 (4.1%) 23 (5.1%) 9 (5.4%) 9 (2.4%)
1000–1500 48 (4.8%) 24 (5.3%) 8 (4.8%) 16 (4.2%)
>1500 6 (0.6%) 3 (0.7%) 2 (1.2%) 1 (0.3%)
No constant income 854 (85.4%) 376 (83.2%) 138 (82.1%) 340 (89.4%)
Having family history of NCDs b 468 (46.8%) 211 (46.7%) 83 (49.4%) 174 (45.8%) 0.735
Physical activity 0.044
Low 654 (65.4%) 306 (67.7%) 102 (60.7%) 246 (64.7%)
Moderate 247 (24.7%) 99 (21.9%) 42 (25.0%) 106 (27.9%)
High 99 (9.9%) 47 (10.4%) 24 (14.3%) 28 (7.4%)
T2D Medications
Oral hypoglycaemic drugs 225 (49.7%) 225 (49.7%) - -
Insulin 171 (37.8%) 171 (37.8%) - -
Both 56 (12.4%) 56 (12.4%) - -
Current cigarette’s smoking 446 (44.6%) 210 (46.5%) 66 (39.3%) 170 (44.7%) 0.279
BMI, kg/m2 28.1 (3.7) 28.2 (3.7) 28.5 (3.5) 27.9 (3.7) 0.189
Waist circumference, cm 105.0 (14.7) 105.5 (14.8) 105.2 (14.7) 104.4 (14.6) 0.547
Fasting glucose, mmol/L 9.4 (4.7) 12.5 (4.6) 10.0 (3.1) 5.6 (1.0) <0.001
HbA1c, mmol/mol 48.4 (18.8) 60.5 (17.3) 50.5 (14.4) 32.9 (8.1) <0.001
HbA1c, % 6.6 (1.7) 7.7 (1.6) 6.7 (1.3) 5.2 (0.7) <0.001
Total cholesterol, mmol/L 5.7 (1.6) 6.2 (1.7) 5.6 (1.3) 5.1 (1.4) <0.001
Triglycerides, mmol/L 2.1 (0.8) 2.3 (0.8) 2.0 (0.6) 1.8 (0.7) <0.001
HDL, mmol/L 1.1 (0.2) 1.0 (0.2) 1.1 (0.3) 1.1 (0.2) <0.001
LDL, mmol/L 4.4 (1.3) 4.6 (1.3) 4.2 (1.2) 4.2 (1.2) <0.001
Systolic blood pressure, mmHg 137.4 (21.4) 137.7 (21.1) 137.2 (20.9) 137.1 (21.9) 0.916
Diastolic blood pressure, mmHg 85.6 (7.2) 85.7 (7.1) 85.5 (7.4) 85.8 (7.3) 0.935
Added sugar intake, g/day 60.6 (22.4) 60.1 (22.0) 59.3 (23.4) 61.8 (22.5) 0.421
Fruits consumption, g/day 163.2 (49.3) 161.4 (49.4) 164.8 (48.2) 164.5 (49.8) 0.591
Vegetable consumption, g/day 282.3 (59.6) 278.8 (59.9) 285.1 (61.8) 285.0 (58.4) 0.267
a Data are presented as mean (SD) for continuous measures and n (%) for categorical measures. b NCDs, non-
communicable diseases, such as stroke, cardiovascular disease, cancer, diabetes mellitus, and hypertension, for father
and mother together. NIS, New Israeli Shekel; BMI, body mass index; HbA1c, haemoglobin A1c; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; T2D, type 2 diabetes.
No statistical differences were detected for population, region, education, income, working status,
smoking, and blood pressure values among groups, except for sex (p = 0.034, Table 1) and physical
activity (p = 0.044, Table 1). Moreover, no significant differences were observed among refugee and
citizen groups (Supplementary Materials Table S1).
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3.2. Associations between Added Sugar Intake Level and Glycaemic Parameters
The mean (SD) of added sugar intake was 60.6 (22.4) g/day, and 44.1% had added sugar intake
above 50 g/day. In all participants, no association was observed between added sugar intake and
diagnosed T2D (p = 0.338, Supplementary Materials Table S2). We evaluated the associations of
added sugar intake and glycaemic indices (FBG and HbA1c) only among those without a clinical
diagnosis of T2D. After adjustment of age, sex, population, region, income, education, smoking,
and physical activity, higher daily added sugar intake was significantly associated with higher levels
of FBG and HbA1c (p = 0.007 for FBG, and p < 0.001 for HbA1c, Figure 3). The same pattern was
observed after including physical activity and BMI in the model, only for HbA1c (p = 0.036) but not
FBG (p = 0.067, Figure 3).
3.3. Associations between Added Sugar Intake and the Risk of Undiagnosed T2D
With multiple adjustments, including age, sex, population, region, income, education, and smoking,
compared with the lowest added sugar intake (<50.0 g/day), the ORs (95% CI) of undiagnosed T2D
were 2.13 (1.22–3.72) for the 50.0–66.0 g/day group, 1.86 (1.06–3.25) for the 67.0–99.0 g/day group,
and 3.52 (1.56–7.93) for the ≥100.0 g/day group (p for trend < 0.001). The association strength was
not substantially changed after further adjusting for physical activity and BMI in Model 2, fruits and
vegetable intake in Model 3, and hypertension plus lipid profile in Model 4 (Table 2). A sensitivity
analysis was conducted among those without a clinical diagnosis of T2D. We defined undiagnosed T2D
based on both FBG and HbA1c. The overall results were similar (p for trend < 0.001, Supplementary
Materials Table S3).
In the stratified analysis by BMI (Table 3), the added sugar intake level was positively associated
with risks of undiagnosed T2D (p for interaction = 0.001, Table 3) only in those with a BMI ≥ 26.7 kg/m2,
where ORs were 6.83 (2.69–17.36) for the 50.0–66.0 g/day group, 4.72 (1.91–11.64) for the ≥67.0 g/day
group (p for trend = 0.037), but not in those with BMI < 26.7 kg/m2. Interestingly, when stratified
by population type (refugees or citizens), the added sugar intake level was positively associated
with risks of undiagnosed T2D (p for interaction = 0.047, Table 3) only in refugees, where ORs were
5.46 (1.75–17.08) for the 50.0–66.0 g/day group, 5.09 (1.64–15.84) for the ≥67.0 g/day group (p for
trend = 0.043), but not in citizens. Meanwhile, in the sensitivity analysis, we defined undiagnosed
T2D based on both FBG and HbA1c, and the findings were similar (Supplementary Materials Table S4).







Model 1 Model 2 Model 3 Model 4
<50.0 g/day 121 (22.1%) 1.00 1.00 1.00 1.00
50.0–66.0 g/day 183 (33.4%) 2.13 (1.22–3.72) 2.01 (1.13–3.59) 2.01 (1.12–3.59) 1.98 (1.09–3.60)
67.0–99.0 g/day 199 (36.3%) 1.86 (1.06–3.25) 1.59 (0.88–2.87) 1.60 (0.89–2.88) 1.54 (0.84–2.81)
≥100.0 g/day 45 (8.2%) 3.52 (1.56–7.93) 2.72 (1.15–6.39) 2.72 (1.15–6.39) 2.71 (1.12–6.54)
p for trend <0.001 <0.001 <0.001 <0.001
Model 1, adjusted for age, sex, population, region, income, education, and smoking; Model 2, Model 1 plus physical
activity and body mass index; Model 3, Model 2 plus fruits and vegetable intake; Model 4, Model 3 plus hypertension
and lipid profile (total cholesterol, triglycerides, HDL, and LDL).
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Table 3. Odds ratio (OR) (95% CI) of undiagnosed T2D by added sugar intake level and other risk
















Men 1.00 1.54 (0.67–3.55) 2.04 (0.93–4.47)
0.058310 (56.6%) 60 (19.4%) 104 (33.5%) 146 (47.1%)
Women 1.00 2.67 (1.19–6.02) 1.42 (0.63–3.18)
0.989238 (43.4%) 61 (25.6%) 79 (33.2%) 98 (41.2%)
Age (Median) 0.318
<59 years 1.00 1.69 (0.71–4.03) 1.64 (0.73–3.69)
0.044259 (47.3 %) 59 (22.8%) 79 (30.5%) 121 (46.7%)
≥59 years 1.00 1.41 (0.62–3.19) 1.06 (0.46–2.40)
0.679289 (52.7%) 62 (21.4%) 104 (36.0%) 123 (42.6%)
BMI (Median) 0.001
<26.7 kg/m2 1.00 1.94 (0.75–5.00) 2.17 (0.84–5.34)















311 (56.8%) 69 (22.2%) 106 (34.1%) 136 (43.7%)
Variables adjusted for age, sex, population, region, income, education, smoking, physical activity, body mass index,
fruits and vegetable intake, hypertension, and lipid profile (total cholesterol, triglycerides, HDL, and LDL).
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undiagnosed T2D based on both FBG and HbA1c. The overall results were similar (p for trend < 0.001, 
Supplementary Materials Table S3). 
In the stratified analysis by BMI (Table 3), the added sugar intake level was positively associated 
with risks of undiagnosed T2D (p for interaction = 0.001, Table 3) only in those with a BMI ≥ 26.7 
kg/m2, where ORs were 6.83 (2.69–17.36) for the 50.0–66.0 g/day group, 4.72 (1.91–11.64) for the ≥67.0 
g/day group (p for trend = 0.037), but not in those with BMI < 26.7 kg/m2. Interestingly, when stratified 
by population type (refugees or citizens), the added sugar intake level was positively associated with 
risks of undiagnosed T2D (p for interaction = 0.047, Table 3) only in refugees, where ORs were 5.46 
(1.75–17.08) for the 50.0–66.0 g/day group, 5.09 (1.64–15.84) for the ≥67.0 g/day group (p for trend = 
Figure 3. Adjusted means of (a) FB ) bA1c by ad ed sugar intake evel among those without
a clinical diagnosis of T2D. Model , j sted for age, sex, opulation, region, income, education,
and smoking; Model 2, Model 1 plus physical activity and body mass index.
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4. Discussion
In the present study, we estimated the prevalence of T2D among Gaza Palestinian adults, and it
showed that higher added sugar consumption is strongly associated with the risk of undiagnosed T2D.
This association was stronger among those with a higher BMI or refugees.
The estimated prevalence of diagnosed T2D was 45.2%, higher than a report on the prevalence of
T2D by UNRWA (15.7%) [7], which serves only refugees, while our study included both refugees and
citizens. Overall, T2D is a considerable burden on the Gazans, in light of the daily living crises that all
Gazans live in [34]. Such crises include high poverty, low wages, and unhealthy camp housing [35]
experienced by the Gaza residents, especially refugees [12,36]. Furthermore, the long durable siege in
the Gaza Strip since 2006 [37], in addition to the three wars in Gaza (2008/2009, 2012, and 2014) [38],
have significantly impacted the health sector and the quality healthcare services [39]. Those traumatic
life events might make the Palestinians experience prolonged stress-related disorders [40], leading to
neuroendocrine dysfunction and increasing the risk of disruption in pancreatic β cells, insulin
sensitivity, and insulin secretion [41], or chronic low-grade inflammation [42], contributing to the
development of T2D [43–45]. On the other hand, it is already mentioned in the literature that aging
influences the health-related quality of life for diabetic patients [46]. A survey also suggested that
T2D patients aged 65 to 84 years had a poorer health-related quality of life (HRQOL) than the
general population, especially regarding different aspects of physical functioning and emotional
disturbances [47]. Additionally, older adults with diabetes have unique issues that may lead to
deterioration in their self-care behaviors [48].
Our study showed that glycaemic control was suboptimal for patients diagnosed with T2D,
and the highest uncontrolled glycaemic rate was 50.0% (95% CI 37–63) in Gaza City. The lowest was
32.3% (95% CI 24–42) in Khan Younis. It is reasonable that Gaza City is considered an urbanized City
compared to the rest of the Gaza Strip regions, while Khan Younis is a Palestinian refugee camp [49].
Most of the residents in Gaza City are citizens, not refugees [50]. Overall, it has appeared that citizens
are relatively less successful in controlling glycaemia than refugees (Figure 2). One of the most
important reasons might be that Palestinian citizens are less likely to have health insurance. In contrast,
Palestinian refugees receive more health services over Palestinian citizens [51,52]. Similarly, in a study
among 1308 diagnosed T2D seeking care at four main PHCs in the Southern West Bank of Palestine,
only 16.1% had HbA1c < 53 mmol/mol (<7.0%) [5], showing a very poor glycaemic control in line with
our results. In another cross-sectional study in the Gaza Strip (n = 369 T2D patients), only one-fifth of
the patients had good glycaemic control (HbA1c < 53 mmol/mol (<7.0%)) [53]. The poor glycaemic
control in our study might also be related to the presence of suboptimal diets, extremely low physical
activity, and the lack of income [53–55].
Furthermore, even at the health system in Gaza, there is a shortage of essential drugs, due to the
blockade’s impact on Gaza [56]. The stock of medications in Gaza mainly depends on foreign support
for securing treatment, which is not permanent [57].
We found that Palestinian adults in Gaza consumed approximately 61.0 g/day of added sugar per
household member, which is above the recommendations of the American Heart Association [21]. In a
community-based cross-sectional study conducted among Palestinians (aged 30–65 years) in the West
Bank, the annual intake of added sugar per household member was 37.8 kg (≈105.0 g/day), and added
sugar intake contributed to 13–14% daily total energy intake among Palestinians (aged 30–65 years) in
the West Bank, according to the results of a community-based cross-sectional study [20]. Additionally,
an ecological epidemiology study reported a strong positive correlation between per capita added
sugar consumption and the prevalence of T2D, whereas Asian countries had the highest correlation
coefficients [58]. Therefore, as far as we know, our study is the first study reporting a direct association
between pure sugar intake and diabetes risk.
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There are growing concerns about the possible health threat posed by high added sugar intake,
as evidenced by the latest American Dietary Guidelines [59]. The excess of sugar intake is an emerging
factor in the current epidemic of obesity and metabolic-associated diseases [60,61]. Interestingly,
we observed a stronger association between added sugar intake with undiagnosed T2D among refugees.
Refugees in Gaza consume relatively more sugar than the citizens (Table 3 and Supplementary Materials
Table S4), despite their poor living and nutritional conditions [62]. About 72% of the Palestinian
refugees in the Gaza Strip receive food supply aids monthly or every three months from humanitarian
agencies, mainly from the UNRWA, World Food Programme, and charity organizations to secure their
food or part of their essential food [18,63]. Such food aids from just UNRWA to each member in one
household include commodities of sugar, flour, cooking oil, powdered milk, and others [64], and all of
these quantities are doubled by UNRWA, for the benefit of the most miserable refugee families [51].
High consumption of added sugar exceeds the energy requirement of refugees who have limited
physical activity levels, which may result in increased de novo lipogenesis [64], increased free fatty
acids [65–67], central obesity, and insulin resistance [68,69]. More studies are needed to elucidate
the mechanisms.
In our stratified analysis by BMI, added sugar intake level was strongly associated with
undiagnosed T2D among those without a clinical diagnosis of T2D, with higher BMI (≥26.7 kg/m2)
rather than those with a lower BMI (<26.7 kg/m2). The concern here is developing to T2D among
those without a clinical diagnosis of T2D, with a higher BMI and consuming more sugar than those
with a normal BMI. Patients with a higher BMI have the chance of elevation of free fatty acids (FFAs),
mainly due to the release of increased fat mass [70]. Further studies are needed to elucidate whether
and how obesity may amplify the effects of excess added sugar intake on insulin action.
Our study has some limitations: First, cross-sectional data do not explore the causal pathways
that underlie the reported association. Second, selection bias is possible, as we recruited only those
visitors who regularly visited the PHCs. Third, recall bias is also possible by using food-frequency
questionnaires. Despite the above limitations, this is the first study that focused on a unique population
(exposed to exceptional circumstances of war, instability, and ongoing violence) to determine the
prevalence of T2D among refugees and citizens.
5. Conclusions
This study involved both citizen and refugee adults aged 40 or older in Gaza Palestinians who
had regularly visited the PHCs, with an estimated prevalence of 45.2% and 16.8%, respectively,
for diagnosed and undiagnosed T2D. Our study indicated that 44.1% of the population had added
sugar intake above 50 g/day, with an average consumption of 60.6 g/day per household member.
Furthermore, our findings also showed that higher consumption of added sugar is associated with a
higher risk of undiagnosed T2D, particularly in refugees or those with higher BMI. Therefore, mass-level
educational awareness campaigns are needed to provide education to Palestinians about diabetes,
balanced diet, and diet-related diseases. Moreover, effective strategies should also be undertaken to
reduce the diabetes burden among Gaza residents, focusing on sugar intake.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/22/8594/s1.
Table S1: Characteristics of study participants, according to population (refugees and citizens). Table S2: Adjusted
odds ratio (95% CI) of the T2D for the sample population participants by average daily added sugar intake
(n = 1000). Table S3: Adjusted OR (95% CI) of undiagnosed T2D by added sugar intake level after including
HbA1c in the definition of outcome (n = 548). Table S4: Adjusted OR (95% CI) of undiagnosed T2D by added
sugar intake level, after including HbA1c in the definition of outcome (n = 548). Figure S1: The selected primary
healthcare centers (PHCs) across the Gaza Strip governorates.
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